BioNTech is a biotechnology company based in Germany, known for its innovative work in the development of immunotherapies and vaccines, particularly in the field of cancer treatment and infectious diseases. Founded in 2008, the company gained significant global attention for its role in the rapid development of one of the first COVID-19 vaccines in collaboration with Pfizer, utilizing mRNA technology. BioNTech aims to harness the body’s immune system to target and destroy disease-causing cells, and its research encompasses a range of therapies, including personalized cancer vaccines and treatments for various viral infections. The company’s focus is on utilizing advanced technologies and platforms to create effective and tailored therapeutic solutions.
BioNTech is shifting its focus from Covid-19 vaccines to mRNA-based cancer treatments, aiming for market approval by 2026. Despite a drop in annual revenue, BioNTech is committed to advancing research,…